These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3008727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.
    Rotenberg SA, Smiley S, Ueffing M, Krauss RS, Chen LB, Weinstein IB.
    Cancer Res; 1990 Feb 01; 50(3):677-85. PubMed ID: 2297708
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition and photoinactivation of the bovine heart mitochondrial F1-ATPase by the cytotoxic agent, dequalinium.
    Zhuo S, Allison WS.
    Biochem Biophys Res Commun; 1988 May 16; 152(3):968-72. PubMed ID: 2897848
    [Abstract] [Full Text] [Related]

  • 9. Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity.
    Mac Neil S, Dawson RA, Crocker G, Tucker WF, Bittiner B, Singleton JG, Hunter T, Tierney DF.
    Br J Dermatol; 1993 Feb 16; 128(2):143-50. PubMed ID: 8457447
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of bovine heart mitochondrial and Paracoccus denitrificans NADH----ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds.
    Anderson WM, Patheja HS, Delinck DL, Baldwin WW, Smiley ST, Chen LB.
    Biochem Int; 1989 Oct 16; 19(4):673-85. PubMed ID: 2515858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting calmodulin for the development of novel cancer chemotherapeutic agents.
    Hait WN.
    Anticancer Drug Des; 1987 Oct 16; 2(2):139-49. PubMed ID: 3329523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discrimination between subtypes of apamin-sensitive Ca(2+)-activated K+ channels by gallamine and a novel bis-quaternary quinolinium cyclophane, UCL 1530.
    Dunn PM, Benton DC, Campos Rosa J, Ganellin CR, Jenkinson DH.
    Br J Pharmacol; 1996 Jan 16; 117(1):35-42. PubMed ID: 8825340
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of calmodulin inhibitors on calmodulin's hydrophobic sites and on the activation of cyclic nucleotide phosphodiesterase by calmodulin.
    Schaeffer P, Luginer C, Follenius-Wund A, Gerard D, Stoclet JC.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1989-96. PubMed ID: 3036157
    [Abstract] [Full Text] [Related]

  • 17. Tissue irritating properties of bis-dequalinium acetate solutions for endodontic use.
    Spangberg L, Pascon EA, Kaufman AY, Safavi K.
    J Endod; 1988 Feb 15; 14(2):88-97. PubMed ID: 3162945
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of methylglyoxal bis(guanylhydrazone)-induced alterations of hamster tumor mitochondria by correlated studies of selective rhodamine binding, ultrastructural damage, DNA replication, and reversibility.
    Nass MM.
    Cancer Res; 1984 Jun 15; 44(6):2677-88. PubMed ID: 6722801
    [Abstract] [Full Text] [Related]

  • 19. Interaction of rhodamine 123 with living cells studied by flow cytometry.
    Darzynkiewicz Z, Traganos F, Staiano-Coico L, Kapuscinski J, Melamed MR.
    Cancer Res; 1982 Mar 15; 42(3):799-806. PubMed ID: 7059978
    [Abstract] [Full Text] [Related]

  • 20. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G, Zimmerman TP.
    Mol Pharmacol; 1984 Sep 15; 26(2):286-92. PubMed ID: 6482875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.